Q1 digital health funding: $4B across 110 deals
Ah, spring: flowers blooming, birds chirping, the smell of fresh-cut grass—and our Q1 recap dropping right on cue. The landscape is greener than this time last year: funding hit $4.0B across 110 deals, the strongest first quarter since pandemic peak, with capital concentrating at the top in ways we haven't seen since 2021. Just 12 companies captured an outsized share of capital, soaking up the most sunlight from investors. The seeds of AI have taken root as a table stakes expectation. And D2C models are in full bloom, with scaled bets and a new wave of AI-native consumer platforms competing to be the front door to care. For the full debrief on spring market conditions, read our Q1 2026 funding and market overview.
Headlines
HHS Changes The U.S. Health IT Office’s Name, And Its Purview
“ONC” is back and focusing on decreasing health record data sharing friction STAT
How A.I. Helped One Man (And His Brother) Build A $1.8B Company
A story about AI efficiency and risk The New York Times
Trump Announces 100% Tariffs On Brand-Name Drugs, With Plenty Of Carveouts
Tariffs are back but not equally applied to all pharmaceuticals STAT
Novo Nordisk Launches Discounted Subscription Program For Wegovy
Self-pay patients can enroll through telehealth providers like Ro, WeightWatchers, and Him & Hers Fierce Healthcare
Recent Funding
- WHOOP lands $575M to scale its wearable platform for personalized health
- Jimini Health, a virtual mental health platform powered by AI agents, nabs $17M
- Avo banks $10M to scale its AI solution for clinical workflows and decision support
- AI-enabled clinical decision support, Ambient Clinical Analytics, inks $5M
- Acurion lands $4.3M for its AI-enabled precision oncology solution